| Gene symbol | LDLR | Synonyms | FH, FHC, FHCL1, LDLCQ2 | Type of gene | protein-coding |
| Chromosome | 19 | Map location | 19p13.2 | dbXrefs | |
| Gene perturbation-related omics dataset | PerturbAtlas | PertOrg | ||||
| Description | low density lipoprotein receptor | ||||
| GTO ID | GTC2180 |
| Trial ID | NCT04080050 |
| Disease | Familial Hypercholesterolemia |
| Altered gene | LDLR |
| Therapeutic/Target gene | Therapeutic gene |
| Therapy | Gene transfer |
| Treatment | RGX-501 |
| Recruitment status | Active, Not Recruiting |
| Title | A Long-term Follow-up Study to Evaluate the Safety and Efficacy of RGX-501 |
| Year | 2019 |
| Country | Canada|Netherlands|United States |
| Company sponsor | REGENXBIO Inc. |
| Other ID(s) | RGX-501-102 |
| Vector information | |||||||||
|
|||||||||
| Cohort 1 | |||||||
|
|||||||